Updated on 9 May 2013
Singapore: Prima BioMed has appointed Dr Russell J Howard as a non-executive director with immediate effect. Dr Howard brings a strong scientific background and significant executive-level industry experience to Prima's board.
Dr Howard, while speaking on his appointment said that, "I am very excited to join the board of Prima. I was drawn to the combination of CVac as a strong lead product candidate in clinical development and a robust technology and manufacturing platform that can drive company value into the future.:
"I look forward to working with the board, the management team, and our scientific advisors as we advance Prima's leadership in the field of personalized immunocellular therapeutics," he added.